Jenscare Scientific Co (HKSE:09877) Construction In Progress: HK$4.12 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09877 Jenscare Scientific Co Ltd HKSE:09877
33 GF Score
Price HK$7.49
! 4 Warning Signs
View Full Analysis

What is Jenscare Scientific Co Construction In Progress?

Jenscare Scientific Co HKSE:09877 +0.60% 33 Construction In Progress is HK$4.12 Mil as of Dec. 2025. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review.

Jenscare Scientific Co's quarterly construction in progress declined from Dec. 2024 (HK$162.69 Mil) to Jun. 2025 (HK$0.00 Mil) but then increased from Jun. 2025 (HK$0.00 Mil) to Dec. 2025 (HK$4.12 Mil).

Jenscare Scientific Co's annual construction in progress increased from Dec. 2023 (HK$93.86 Mil) to Dec. 2024 (HK$162.69 Mil) but then declined from Dec. 2024 (HK$162.69 Mil) to Dec. 2025 (HK$4.12 Mil).

Jenscare Scientific Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Jenscare Scientific Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jenscare Scientific Co Construction In Progress Chart

Jenscare Scientific Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial 16.13 16.71 93.86 162.69 4.12

Jenscare Scientific Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 93.86 0.00 162.69 0.00 4.12
HKSE:09877
33GF Score
Jenscare Scientific Co Ltd HKSE:09877
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jenscare Scientific Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of HK$4.12 Mil mean?
Jenscare Scientific Co (HKSE:09877) has a Construction In Progress of HK$4.12 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Jenscare Scientific Co and its competitors.
Is Jenscare Scientific Co's Construction In Progress too high?
Jenscare Scientific Co's current Construction In Progress is HK$4.12 Mil. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's Construction In Progress compare to ABT and SYK?
Jenscare Scientific Co's Construction In Progress of HK$4.12 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Jenscare Scientific Co and its competitors. Jenscare Scientific Co's current Construction In Progress is HK$4.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current Construction In Progress of HK$4.12 Mil. The current Construction In Progress is HK$4.12 Mil. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current Construction In Progress is HK$4.12 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jenscare Scientific Co Business Description

Address No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score

Get the complete analysis for HKSE:09877

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$7.49
Price